When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1 - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Biochemical Society Transactions Année : 2016

When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1

Résumé

Dendrogenin A (DDA) is the first steroidal alkaloid (SA) to be identified in human tissues to date and arises from the stereoselective enzymatic conjugation of 5,6α-epoxycholesterol (5,6α-EC) with histamine (HA). DDA induces the re-differentiation of cancer cellsin vitroandin vivoand prevents breast cancer (BC) and melanoma development in mice, evidencing its protective role against oncogenesis. In addition, DDA production is lower in BCs compared with normal tissues, suggesting a deregulation of its biosynthesis during carcinogenesis. The discovery of DDA reveals the existence of a new metabolic pathway in mammals which lies at the crossroads of cholesterol and HA metabolism and which leads to the production of this metabolic tumour suppressor.
Fichier principal
Vignette du fichier
bst0440631.pdf (386.91 Ko) Télécharger le fichier
Loading...

Dates et versions

inserm-02380631 , version 1 (26-11-2019)

Identifiants

Citer

Marc Poirot, Sandrine Silvente-Poirot. When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1. Biochemical Society Transactions, 2016, 44 (2), pp.631-637. ⟨10.1042/BST20150232⟩. ⟨inserm-02380631⟩
44 Consultations
378 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More